Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia

被引:39
|
作者
Liu, Dongping [2 ]
He, Qingjuan [2 ,3 ]
Liu, Caigang [1 ]
机构
[1] China Medial Univ, Affiliated Hosp 1, Dept Oncol, Breast Surg Ward, Shenyang 110001, Liaoning, Peoples R China
[2] China Medial Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
[3] Eighth Peoples Hosp Qindao, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
关键词
cyclooxygenase-2; dysplasia; Helicobacter pylori; intestinal metaplasia; vascular endothelial growth factor; CANCER; PATHWAY; ASSOCIATION;
D O I
10.1111/j.1440-1746.2009.06168.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: To examine the rate of Helicobacter pylori infection and the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric mucosa with intestinal metaplasia or dysplasia, and explore their correlations in precancerous gastric lesions. Methods: A total of 172 patients were included in the study. H. pylori infection was evaluated by hematoxylin-eosin and modified Giemsa staining. The expression of COX-2 and VEGF proteins was detected by immunohistochemistry. Results: The rates of H. pylori infection in gastric mucosal dysplasia (DYS), intestinal metaplasia in gastric mucosa (IM), chronic atrophic gastritis (CAG) and chronic superficial gastritis (CSG) patients were significant differences (P = 0.001). The average optical density (AOD) values of COX-2 staining in CSG, CAG, IM and DYS patients were 13.81 +/- 5.53, 45.28 +/- 21.44, 73.67 +/- 26.02 and 91.23 +/- 45.11, respectively, with significant differences among CSG, CAG and IM patients (P = 0.037, 0.001 and 0.047 for CSG vs CAG, CSG vs IM and CAG vs IM, respectively). The expression level of VEGF in DYS patients was significantly higher than those in other patients (P = 0.001, 0.001 and 0.001 for DYS vs CSG, DYS vs CAG and DYS vs IM, respectively). The expression levels of COX-2 in H. pylori-positive IM, CAG and DYS patients were significantly higher than those in H. pylori-negative counterparts (P = 0.043, 0.009, 0.001, respectively). Additionally, the expression level of COX-2 was positively correlated with that of VEGF with the aggravation of gastric mucosal lesions (r = 0.640, P = 0.006). Conclusion: H. pylori infection might be able to induce the expression of COX-2 in precancerous gastric lesions, which in turn upregulates the expression of VEGF.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 50 条
  • [41] Interaction of Cyclooxygenase-2 Promoter Polymorphisms With Helicobacter pylori Infection and Risk of Gastric Cancer
    Zhang, Xuemei
    Zhong, Rong
    Zhang, Zhi
    Yuan, Juxiang
    Liu, Li
    Wang, Yan
    Kadlubar, Susan
    Feng, Fumin
    Miao, Xiaoping
    MOLECULAR CARCINOGENESIS, 2011, 50 (11) : 876 - 883
  • [42] Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection
    Sung, Jihee
    Kim, Nayoung
    Lee, Jongchan
    Hwang, Young-Jae
    Kim, Hyoung Woo
    Chung, Jung Wha
    Kim, Jin-Wook
    Lee, Dong Ho
    GUT AND LIVER, 2018, 12 (02) : 158 - 164
  • [43] Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
    Sung, JJY
    Leung, WK
    Go, MYY
    To, KF
    Cheng, ASL
    Ng, EKW
    Chan, FKL
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (03): : 729 - 735
  • [44] The interaction of H-pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer
    Wu, CY
    Wu, MS
    Chen, CJ
    Li, MC
    Lin, JT
    Chen, GH
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (01) : 50 - 55
  • [45] Expressions of cyclooxygenase-2 and vascular endothelial growth factor in colorectal adenoma
    S. Park
    H. Uetake
    K. Sugihara
    Annals of Surgical Oncology, 2004, 11 : S107 - S107
  • [46] LOCAL IMMUNE-RESPONSE IN GASTRIC-MUCOSA TO HELICOBACTER-PYLORI INFECTION WITH AND WITHOUT INTESTINAL METAPLASIA
    SUGIYAMA, T
    FURUYAMA, S
    AWAKAWA, T
    KOBAYASHI, T
    YABANA, T
    YACHI, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1993, 5 : S119 - S122
  • [47] Expressions of cyclooxygenase-2 and vascular endothelial growth factor in colorectal adenoma
    Park, S
    Uetake, H
    Sugihara, K
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S107 - S107
  • [48] Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis
    Ceyhan, Seyit Temel
    Onguru, Onder
    Baser, Iskender
    Gunhan, Omer
    FERTILITY AND STERILITY, 2008, 90 (04) : 988 - 993
  • [49] The expression of HER2 in Helicobacter Pylori infected intestinal metaplasia and gastric cancer
    Nakajima, Noriko
    Ito, Yoko
    Yokoyama, Kiyoshi
    Hayakawa, Satoshi
    Mizumo, Shigeaki
    Kato, Kimitoshi
    Kinukawa, Noriko
    Norimichi, Nemoto
    Yasuyuki, Arakawa
    Lacy, Eric R.
    GASTROENTEROLOGY, 2006, 130 (04) : A275 - A275
  • [50] Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
    De Re, Valli
    Orzes, Enrico
    Canzonieri, Vincenzo
    Maiero, Stefania
    Fornasarig, Mara
    Alessandrini, Lara
    Cervo, Silvia
    Steffan, Agostino
    Zanette, Giorgio
    Mazzon, Cinzia
    De Paoli, Paolo
    Cannizzaro, Renato
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7